FR
Fabrice Rosenstiehl
Chief Operating Officer at SEPARATIVE
Paris, Île-de-France
Overview
Fabrice Rosenstiehl is a Chief Executive Officer with expertise in business development, sales, marketing, and market access within the medical technology industry, particularly in cardiology, DTx, and neuroscience. With a successful track record at companies like Corstim and Digitsole, he has demonstrated strong leadership in driving operational excellence and customer satisfaction, while also investing in various startups in the digital health sector.
Work Experience
Director TRI Europe
2022 - Current
Strategic and Business Advisor - Strategic Planning & Execution - Fund Raising
Chief Operating Officer
2022
Founder, Senior Advisor
2019
Consultant and senior advisor, 1/ Margin expansion through improved customer experience and business model transformation (Life Time Value optimization) 2/ Demand generation (advocacy programmes in the health sector) 3/ Systemic reorganisation Customers range from - Seed & Series A startups to Private Equity - CEO, CMO, COO strategic discussions / advising, and operational discussions with their teams
Business Angel
2018
Chairman & CEO
2022 - 2022
Chief Operating Officer
2021 - 2021
General Manager
2020 - 2021
Group Operations Director
2019 - 2019
Head of Service Business EMEA
2017 - 2018
Head of Customer and Business Development EMEA
2008 - 2016
EMEA Growth Probes Manager
2007 - 2008
Region Services Manager MEA
2003 - 2007
Six Sigma Black Belt
2001 - 2002
GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers.
Raised $5,524,660,836.00 from Bill & Melinda Gates Foundation.
Supplier Manager
2000 - 2001